Professional Documents
Culture Documents
Drug Study
Drug Study
BARBOZA, SHERILYN
TAYSA, DIANA ROSE
BSN3-NCA
DRUG STUDY
NAME MECHANISM/MODE OF INDICATION AND SIDE EFFECTS/ADVERSE NURSING CONSIDERATION
ACTION CONTRAINDICATION EFFECTS
SKIN: Dermatitis,
ABIDAL, GRACE ALT-NCA2
BARBOZA, SHERILYN
TAYSA, DIANA ROSE
BSN3-NCA
diaphoresis,
erythema multiforme,
flushing,
photosensitivity,
pru- ritus, rash,
urticaria
● Take baseline
BP and heart
rate with the
patient in
sitting
position before
initiation of
treatment with
transdermal
preparations.
One hour after
transdermal
ABIDAL, GRACE ALT-NCA2
BARBOZA, SHERILYN
TAYSA, DIANA ROSE
BSN3-NCA
(ointment or
unit)
medication has
been applied,
check BP and
pulse again
with the
patient in
sitting
position.
Report
measurements to
the physician.
● Be aware that
local burning
ABIDAL, GRACE ALT-NCA2
BARBOZA, SHERILYN
TAYSA, DIANA ROSE
BSN3-NCA
or tingling
from the
sublingual form
has no clinical
significance.
● Be alert for
overdose
symptoms:
Hypotension,
tachycardia;
warm, flushed
skin becoming
cold and
cyanotic;
headache,
palpitations,
confusion,
nausea,
vomiting,
moderate fever,
and paralysis.
Tissue hypoxia
leads to coma,
convulsions,
cardiovascular
collapse. Death
can occur from
asphyxia.